Masimo (NASDAQ:MASI) rose 3% after activist investor Politan Capital Management won two board seats after a bitter proxy ...

Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Masimo’s Joe Kiani an avid audiophile, is set to set to walk from the Company he founded, with the former CEO, who acquired ...

Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.

Koffey was elected to Masimo’s board in June 2023 along with Politan-backed candidate Michelle Brennan, a former Johnson & Johnson executive. The hedge fund argued that Masimo’s $1 billion acquisition ...

Shares of Masimo (NASDAQ: MASI) are trading nearly 3% higher early on Friday after activist investor Politan Capital Management, owner of a 9% stake in the company, disclosed its two independent board ...

The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...

Court documents unsealed on Friday show Masimo CEO Joe Kiani shared material non-public information with an investor in March ...